{"id":"W4387811549","doi":"10.1016/j.annonc.2023.09.1853","title":"667P Efficacy and safety of larotrectinib (laro) as first-line treatment for patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Medicine; Trk receptor; Internal medicine; Cancer; Sarcoma; Surgery; Oncology; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Clinical trial; Phases of clinical research; Pathology; Receptor; Neurotrophin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002007542,0.0002154858,0.0006608271,0.0001619442,0.0001410558,0.0004242075,0.0001545128,0.0003244498,0.002140006],"category_scores_gemma":[0.000403788,0.00009922745,0.0005491433,0.0001857687,0.0001608879,0.0003402596,0.0001255661,0.001015711,0.0005283341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004473286,"about_ca_system_score_gemma":0.0004129305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007366974,"about_ca_topic_score_gemma":0.001687576,"domain_scores_codex":[0.9998913,0.0000268512,0.000006064417,0.00001809315,0.00001847208,0.00003920491],"domain_scores_gemma":[0.9998852,0.000021658,0.00002676493,0.000006080996,0.00001396211,0.0000462543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1939127,0.00680428,0.04821648,0.001182421,0.001693388,0.001427127,0.0001925857,0.004076407,0.08958785,0.0006624968,0.01267659,0.6395677],"study_design_scores_gemma":[0.07347403,0.3529615,0.4150611,0.000530412,0.006009349,0.01010184,0.0007701663,0.01434266,0.06307685,0.001498987,0.06194676,0.0002264866],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880029,0.006637743,0.0001889433,0.0005829736,0.0001030534,0.0000599669,0.0005630192,0.00006193385,0.003799438],"genre_scores_gemma":[0.9948154,0.001903695,0.0001578037,0.0004282486,0.00004492835,0.00003500295,0.0009015774,0.00001014749,0.001703157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002140006,"threshold_uncertainty_score":0.007159054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06584519936618642,"score_gpt":0.385936079237598,"score_spread":0.3200908798714116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}